FDA Inspection 1215337 — Department of Defense - Navy (U.S. Naval Hospital Naples)
The FDA completed an inspection of Department of Defense - Navy (U.S. Naval Hospital Naples) on July 21, 2023 in Naples. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 21, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Naples (Italy)